The Relationship Between HMGB1 and Autophagy in the Pathogenesis of Diabetes and Its Complications

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2023 Apr 17

PMID 37065747

Authors

Kun Yang

Feng Cao

Weili Wang

Zhenyu Tian

Lu Yang

Affiliations

Soon will be listed here.

Abstract

Diabetes mellitus is a chronic metabolic disorder characterized by elevated blood glucose levels and has become the third leading threat to human health after cancer and cardiovascular disease. Recent studies have shown that autophagy is closely associated with diabetes. Under normal physiological conditions, autophagy promotes cellular homeostasis, reduces damage to healthy tissues and has bidirectional effects on regulating diabetes. However, under pathological conditions, unregulated autophagy activation leads to cell death and may contribute to the progression of diabetes. Therefore, restoring normal autophagy may be a key strategy to treat diabetes. High-mobility group box 1 protein (HMGB1) is a chromatin protein that is mainly present in the nucleus and can be actively secreted or passively released from necrotic, apoptotic, and inflammatory cells. HMGB1 can induce autophagy by activating various pathways. Studies have shown that HMGB1 plays an important role in insulin resistance and diabetes. In this review, we will introduce the biological and structural characteristics of HMGB1 and summarize the existing knowledge on the relationship between HMGB1, autophagy, diabetes, and diabetic complications. We will also summarize potential therapeutic strategies that may be useful for the prevention and treatment of diabetes and its complications.

Citing Articles

Autophagy Regulates Ferroptosis-Mediated Diabetic Liver Injury by Modulating the Degradation of ACSL4.

Wu L, Lai W, Li L, Yang S, Li F, Yang C J Diabetes Res. 2025; 2024:7146054.

PMID: 39741964 PMC: 11688137. DOI: 10.1155/jdr/7146054.

Acupuncture and Drug Combination Therapy for Abnormal Glucose Metabolism: Exploring Synergistic Enhancement and Reduced Toxicity Mechanisms.

Tian X, Wang W, Zhang L, Wang L, Zhang K, Ge X Diabetes Metab Syndr Obes. 2024; 17:4525-4537.

PMID: 39624791 PMC: 11611509. DOI: 10.2147/DMSO.S492626.

A pan-cancer analysis of the oncogenic function of HMGB1 in human tumors.

Yang H, Zhao X, Li X, Wang X, Pu Y, Wei D Biochem Biophys Rep. 2024; 40:101851.

PMID: 39582753 PMC: 11584604. DOI: 10.1016/j.bbrep.2024.101851.

Diacerein and myo-inositol alleviate letrozole-induced PCOS via modulation of HMGB1, SIRT1, and NF-kB: A comparative study.

Khodir S, Sweed E, Motawea S, Al-Gholam M, Sobhy Elnaidany S, Dayer M Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39432066 DOI: 10.1007/s00210-024-03497-7.

Cytotoxic Impact of Naringenin-Loaded Solid Lipid Nanoparticles on RIN5F Pancreatic β Cells Autophagy Blockage.

Pour P, Nouri Z, Ghasemi D, Sajadimajd S, Farzaei M Recent Adv Drug Deliv Formul. 2024; 18(4):304-314.

PMID: 39356101 DOI: 10.2174/0126673878297658240804192222.

References

Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N . Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9 edition. Diabetes Res Clin Pract. 2019; 157:107843. DOI: 10.1016/j.diabres.2019.107843. View

Watson C, Moulin D, Watt-Watson J, Gordon A, Eisenhoffer J . Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain. 2003; 105(1-2):71-8. DOI: 10.1016/s0304-3959(03)00160-x. View

Yao Q, Ke Z, Guo S, Yang X, Zhang F, Liu X . Curcumin protects against diabetic cardiomyopathy by promoting autophagy and alleviating apoptosis. J Mol Cell Cardiol. 2018; 124:26-34. DOI: 10.1016/j.yjmcc.2018.10.004. View

Diao H, Kang Z, Han F, Jiang W . Astilbin protects diabetic rat heart against ischemia-reperfusion injury via blockade of HMGB1-dependent NF-κB signaling pathway. Food Chem Toxicol. 2013; 63:104-10. DOI: 10.1016/j.fct.2013.10.045. View

Bugliani M, Mossuto S, Grano F, Suleiman M, Marselli L, Boggi U . Modulation of Autophagy Influences the Function and Survival of Human Pancreatic Beta Cells Under Endoplasmic Reticulum Stress Conditions and in Type 2 Diabetes. Front Endocrinol (Lausanne). 2019; 10:52. PMC: 6399112. DOI: 10.3389/fendo.2019.00052. View

Thakur V, Nargis S, Gonzalez M, Pradhan S, Terreros D, Chattopadhyay M . Role of Glycyrrhizin in the Reduction of Inflammation in Diabetic Kidney Disease. Nephron. 2017; 137(2):137-147. DOI: 10.1159/000477820. View

Hou B, Qiang G, Zhao Y, Yang X, Chen X, Yan Y . Salvianolic Acid A Protects Against Diabetic Nephropathy through Ameliorating Glomerular Endothelial Dysfunction via Inhibiting AGE-RAGE Signaling. Cell Physiol Biochem. 2017; 44(6):2378-2394. DOI: 10.1159/000486154. View

Jeon Y, Roh H, Jung J, Ahn H, Lee J, Yun C . Antifibrotic Effects of High-Mobility Group Box 1 Protein Inhibitor (Glycyrrhizin) on Keloid Fibroblasts and Keloid Spheroids through Reduction of Autophagy and Induction of Apoptosis. Int J Mol Sci. 2019; 20(17). PMC: 6747471. DOI: 10.3390/ijms20174134. View

Chung H, Nam H, Nguyen-Phuong T, Jang J, Hong S, Choi S . The blockade of cytoplasmic HMGB1 modulates the autophagy/apoptosis checkpoint in stressed islet beta cells. Biochem Biophys Res Commun. 2020; 534:1053-1058. DOI: 10.1016/j.bbrc.2020.10.038. View

10.

Wang J, Wang L, Zhou J, Qin A, Chen Z . The protective effect of formononetin on cognitive impairment in streptozotocin (STZ)-induced diabetic mice. Biomed Pharmacother. 2018; 106:1250-1257. DOI: 10.1016/j.biopha.2018.07.063. View

11.

Tsao C, Huang W, Liu T, Wang P, Liou C, Lin T . Expression of high-mobility group box protein 1 in diabetic foot atherogenesis. Genet Mol Res. 2015; 14(2):4521-31. DOI: 10.4238/2015.May.4.10. View

12.

Lee Y, Kim J, Park K, Lee M . β-cell autophagy: Mechanism and role in β-cell dysfunction. Mol Metab. 2019; 27S:S92-S103. PMC: 6768496. DOI: 10.1016/j.molmet.2019.06.014. View

13.

Toledo M, Singh R . Complement C3 and Autophagy Keep the β Cell Alive. Cell Metab. 2019; 29(1):4-6. DOI: 10.1016/j.cmet.2018.12.010. View

14.

Xue J, Suarez J, Minaai M, Li S, Gaudino G, Pass H . HMGB1 as a therapeutic target in disease. J Cell Physiol. 2020; 236(5):3406-3419. PMC: 8104204. DOI: 10.1002/jcp.30125. View

15.

Ivanov V, Buyko E, Ufandeev A, Nevskaya K, Udut V, Zima A . Insulin Resistance in Experimental Type 1 Diabetes Mellitus. Bull Exp Biol Med. 2022; 172(6):691-694. DOI: 10.1007/s10517-022-05458-7. View

16.

Andersson U, Tracey K . HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol. 2011; 29:139-62. PMC: 4536551. DOI: 10.1146/annurev-immunol-030409-101323. View

17.

Tziomalos K, Athyros V . Diabetic Nephropathy: New Risk Factors and Improvements in Diagnosis. Rev Diabet Stud. 2015; 12(1-2):110-8. PMC: 5397986. DOI: 10.1900/RDS.2015.12.110. View

18.

Shao N, Yu X, Ma X, Lin W, Hao M, Kuang H . Exenatide Delays the Progression of Nonalcoholic Fatty Liver Disease in C57BL/6 Mice, Which May Involve Inhibition of the NLRP3 Inflammasome through the Mitophagy Pathway. Gastroenterol Res Pract. 2018; 2018:1864307. PMC: 5925008. DOI: 10.1155/2018/1864307. View

19.

Muralidharan C, Conteh A, Marasco M, Crowder J, Kuipers J, de Boer P . Pancreatic beta cell autophagy is impaired in type 1 diabetes. Diabetologia. 2021; 64(4):865-877. PMC: 7940272. DOI: 10.1007/s00125-021-05387-6. View

20.

Marasco M, Conteh A, Reissaus C, Cupit 5th J, Appleman E, Mirmira R . Interleukin-6 Reduces β-Cell Oxidative Stress by Linking Autophagy With the Antioxidant Response. Diabetes. 2018; 67(8):1576-1588. PMC: 6054440. DOI: 10.2337/db17-1280. View